Innovation, Manufacture & Regulation
We begin with this WHO-SEARO publication titled Intellectual Property and Access to medicines. Papers and Perspectives (2010): This is a good introduction to Intellectual Property Rights. It was developed for capacity-building in the area of intellectual property and public health, the WHO Regional Office for Africa and the WHO Regional Office for South-East Asia and remains a useful text. Its publication is intended to facilitate the conducting of further courses on the implications of intellectual property rights on access to medicines.
For those who would like to go deeper, we provide four original official texts: These are:
- TRIPS Agreement – Text of the Agreement on Trade-Related Aspects of Intellectual Property Rights
- Doha Declaration – Declaration on TRIPS Agreement and Public Health, 14th November, 2021
- Guidelines for the Examination of Pharmaceutical Patents – Developing a Public Health Perspectives, Charles Correa, University of Buenos Aires, International Centre for Trade and Sustainable Development, 2012
- Indian Patent Act, 1970
The last of these, the Indian Patent Act is an example of a very good alternative to the current WTO defined Intellectual Property Rights Regime. India had to replace this Act. We provide one paper on why such a shift from the earlier Indian patent regime to the new IPR Regime, did not work for low and middle income countries in this paper Innovation Patterns,, Limits to Learning and the pathway of neo-liberal globalization. Dinesh Abrol et al, 2013. We also attach an official document produced by The Sector Innovation Council for the Health Sector in 2013. This report is one of those many official documents, prepared with great effort, but poorly circulated and little referred to. Placed here for reference.
